Reimagining Biomarkers to Illuminate the Right Patient Population & Advance Precision Medicine Impact
Time: 9:00 am
day: Pre-Conference Workshop Day
Despite the ignited excitement for a next generation therapeutic with potential to reduce mortality, progress in clinical studies has been hindered by challenges in identifying suitable biomarkers.
Join this interactive deep dive to harness biomarkers to better stratify patient populations and understand how best to target them to unlock the therapeutic potential of cardiovascular cell and gene therapy.
- Navigating biomarkers in cardiovascular drug development that span all modalities – genetics, peripheral proteins, lipids, inflammatory markers as well as imaging and device-derved markers
- De-risking cardiovascular outcome trials with early proof of concept biomarkers remains a major challenge
- Exploratory omic analyses in cardiovascular outcomes offer hypothesis generation for precision medicine